Sign In
Buy PGEN
$3.81
-0.0500 (-1.30%)
At Close: Jun 03, 2026
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08:30am, Thursday, 09'th Jan 2025
GERMANTOWN, Md. , Jan. 9, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
02:34pm, Thursday, 02'nd Jan 2025
The upside in Precigen's stock comes after it completes the rolling submission of an FDA filing for its first potentially marketed product.
– PRGN-2012 has the potential to be the first FDA-approved therapeutic for the treatment of adults with RRP, a rare and devastating chronic disease for which the current standard-of-care is repe
Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock
09:00am, Friday, 27'th Dec 2024
GERMANTOWN, Md. , Dec. 27, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
06:45pm, Thursday, 14'th Nov 2024
Precigen, Inc. (PGEN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.08 per share a year ago.
Precigen Reports Third Quarter 2024 Financial Results and Business Updates
04:30pm, Thursday, 14'th Nov 2024
– Completed pre-BLA meeting with FDA with full alignment on content of BLA, including CMC module, and path for fourth quarter 2024 rolling BLA submission for PRGN-2012 † in RRP under acceler
Precigen to Participate in the Stifel 2024 Healthcare Conference
04:05pm, Tuesday, 12'th Nov 2024
GERMANTOWN, Md. , Nov. 12, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives
Precigen to Participate in the 2024 Cantor Global Healthcare Conference
04:30pm, Monday, 16'th Sep 2024
GERMANTOWN, Md. , Sept. 16, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives o
3 Penny Stocks To Buy With Just $50
07:54am, Sunday, 15'th Sep 2024
Penny stocks are an interesting category. While they have the potential to produce significant long-run gains, you should never bet money on these stocks that you can't afford to lose.
3 Penny Stocks to Buy With $500
10:20am, Friday, 30'th Aug 2024
Are you interested in investing in penny stocks?
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday.
Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript
07:03pm, Wednesday, 14'th Aug 2024
Precigen, Inc. (NASDAQ:PGEN ) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Steven Harasym - VP, IR Helen Sabzevari - President & CEO Harry Thomasian - CFO Phil Tenn
Precigen, Inc. (PGEN) Reports Q2 Loss, Misses Revenue Estimates
06:31pm, Wednesday, 14'th Aug 2024
Precigen, Inc. (PGEN) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.08 per share a year ago.
Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates
04:05pm, Wednesday, 14'th Aug 2024
– In June 2024, the Company announced groundbreaking pivotal study data for PRGN-2012 gene therapy at the 2024 ASCO annual meeting in which more than half of RRP patients achieved Complete Response
Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th
08:00am, Friday, 09'th Aug 2024
GERMANTOWN, Md. , Aug. 9, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of
